{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:13:11Z","timestamp":1782299591443,"version":"3.54.5"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"BPSU Sir Peter Tizard Bursary"},{"DOI":"10.13039\/501100018817","name":"LUPUS UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018817","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK\u2019s Experimental Arthritis Treatment Centre for Children"},{"name":"Versus Arthritis, Alder Hey Children\u2019s National Health Service Foundation Trust"},{"name":"Alder Hey Charity"},{"DOI":"10.13039\/501100000836","name":"University of Liverpool","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The primary objective was to define the incidence of JSLE in children &amp;lt;16\u2009years of age in the UK and Republic of Ireland (ROI). The secondary objective was to describe presenting features, classification criteria, initial management and disease damage in newly presenting JSLE patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective JSLE epidemiological study was undertaken between September 2017 and September 2019 with support of the British Paediatric Surveillance Unit and other professional groups involved in diagnosis and management of JSLE patients. Treating consultants reported all cases of JSLE seen. A follow-up study at 1\u2009year examined management and progression of disease and treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There were 124 incident cases included in the final analysis. Incidence was estimated using ACR-1997 classification criteria (0.36\/100\u2009000), SLICC-2012 classification criteria (0.41\/100\u2009000) and clinician expert opinion (0.46\/100\u2009000). A high disease burden was seen, with 71.0% of patients requiring ongoing systemic CS treatment at 1\u2009year; 98.2% receiving immunomodulatory treatment; and 20.4% accruing damage in the year following diagnosis (predominantly neuropsychiatric-related), with substantial involvement from multiple speciality teams.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The minimum UK and ROI incidence of JSLE is between 0.36 and 0.46\/100\u2009000, depending on the case definition used. Challenges in classification of patients with JSLE are highlighted, but overall this study supports the use of SLICC-2012 classification criteria. The high levels of disease damage and ongoing CS use 1\u2009year after diagnosis is concerning, highlighting the need for further interventions to improve outcomes in JSLE.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac064","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T12:13:30Z","timestamp":1643285610000},"page":"4097-4106","source":"Crossref","is-referenced-by-count":17,"title":["Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7162-7578","authenticated-orcid":false,"given":"Hanna","family":"Lythgoe","sequence":"first","affiliation":[{"name":"Department of Paediatric Rheumatology, Alder Hey Children\u2019s NHS Foundation Trust , Liverpool"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve M D","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Paediatric Rheumatology, Alder Hey Children\u2019s NHS Foundation Trust , Liverpool"},{"name":"Department of Women\u2019s and Children\u2019s, Institute of Life Course and Medical Sciences, University of Liverpool , Liverpool"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orla G","family":"Killeen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Great Ormond Street Children\u2019s Hospital , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Pilkington","sequence":"additional","affiliation":[{"name":"Department of Paediatric Rheumatology, Children\u2019s Health Ireland (CHI) at Crumlin , Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4965-3259","authenticated-orcid":false,"given":"Clare E","family":"Pain","sequence":"additional","affiliation":[{"name":"Department of Paediatric Rheumatology, Alder Hey Children\u2019s NHS Foundation Trust , Liverpool"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5400-9911","authenticated-orcid":false,"given":"Michael W","family":"Beresford","sequence":"additional","affiliation":[{"name":"Department of Paediatric Rheumatology, Alder Hey Children\u2019s NHS Foundation Trust , Liverpool"},{"name":"Department of Women\u2019s and Children\u2019s, Institute of Life Course and Medical Sciences, University of Liverpool , Liverpool"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"in association with the British Paediatric Surveillance Unit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"McDonagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Tizard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiannis","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"2022100812085941200_keac064-B1","doi-asserted-by":"crossref","first-page":"108274","DOI":"10.1016\/j.clim.2019.108274","article-title":"Juvenile-onset systemic lupus erythematosus: update on clinical presentation, pathophysiology and treatment options [Internet]","volume":"209","author":"Smith","year":"2019","journal-title":"Clinical Immunology"},{"key":"2022100812085941200_keac064-B2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.berh.2018.02.001","article-title":"Juvenile-onset systemic lupus erythematosus (jSLE) - Pathophysiological concepts and treatment options","volume":"31","author":"Hedrich","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2022100812085941200_keac064-B3","first-page":"1725","article-title":"1997 Update of the 1982 American College of Rheumatology revised criteria for classification of systemic lupus erythematosus criterion","volume":"40","author":"Hochberg","year":"1997","journal-title":"Am Coll Rheumatol"},{"key":"2022100812085941200_keac064-B4","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2022100812085941200_keac064-B5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2022100812085941200_keac064-B6","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"2022100812085941200_keac064-B7","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":". Arthritis Rheum"},{"key":"2022100812085941200_keac064-B8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/annrheumdis-2014-206334","article-title":"The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012","volume":"75","author":"Rees","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022100812085941200_keac064-B9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/pds.1199","article-title":"Incidence of clinically diagnosed systemic lupus erythematosus 1992-1998 using the UK General Practice Research Database","volume":"15","author":"Nightingale","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022100812085941200_keac064-B10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/rheumatology\/32.2.110","article-title":"The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990","volume":"32","author":"Hopkinson","year":"1993","journal-title":"Br J Rheumatol"},{"key":"2022100812085941200_keac064-B11","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/0961203311412096","article-title":"Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus","volume":"20","author":"Pineles","year":"2011","journal-title":"Lupus"},{"key":"2022100812085941200_keac064-B12","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/art.34472","article-title":"Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population","volume":"64","author":"Hiraki","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2022100812085941200_keac064-B13","author":"Royal College of Paediatrics and Child Health. British Paediatric Surveillance Unit"},{"key":"2022100812085941200_keac064-B14","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1002\/art.22048","article-title":"A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus","volume":"54","author":"Guti\u00e9rrez-Su\u00e1rez","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2022100812085941200_keac064-B15","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/art.34410","article-title":"Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort","volume":"64","author":"Watson","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2022100812085941200_keac064-B16","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1177\/0961203317700484","article-title":"Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis","volume":"26","author":"Lythgoe","year":"2017","journal-title":"Lupus"},{"key":"2022100812085941200_keac064-B17","author":"Office for National Statistics. Population Estimates"},{"key":"2022100812085941200_keac064-B18","author":"Central Statistics Office. Estimated Populations"},{"key":"2022100812085941200_keac064-B19","author":"Office for National Statistics"},{"key":"2022100812085941200_keac064-B20","first-page":"440","article-title":"Performance of the new SLICC classification criteria in childhood systemic lupus erythematosus: a multicentre study","volume":"32","author":"Sag","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2022100812085941200_keac064-B21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/rheumatology\/keu278","article-title":"Comparison between three systems of classification criteria in juvenile systemic lupus erythematous","volume":"54","author":"Fonseca","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2022100812085941200_keac064-B22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s42358-019-0062-z","article-title":"Comparison among ACR1997, SLICC and the new EULAR\/ACR classification criteria in childhood-onset systemic lupus erythematosus","volume":"59","author":"Rodrigues Fonseca","year":"2019","journal-title":"Adv Rheumatol"},{"key":"2022100812085941200_keac064-B23","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3899\/jrheum.200871","article-title":"The performances of the ACR 1997, SLICC 2012, and EULAR\/ACR 2019 classification criteria in pediatric systemic lupus erythematosus","volume":"48","author":"Batu","year":"2021","journal-title":"J Rheumatol"},{"key":"2022100812085941200_keac064-B24","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1093\/rheumatology\/keab210","article-title":"Limited sensitivity and specificity of the ACR\/EULAR-2019 classification criteria for SLE in JSLE?\u2014observations from the UK JSLE Cohort Study","volume":"60","author":"Smith","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2022100812085941200_keac064-B25","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/annrheumdis-2016-210960","article-title":"European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative","volume":"76","author":"Groot","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022100812085941200_keac064-B26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00296-016-3450-2","article-title":"Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register","volume":"36","author":"Sousa","year":"2016","journal-title":"Rheumatol Int"},{"key":"2022100812085941200_keac064-B27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/0961203320909156","article-title":"Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups","volume":"29","author":"Massias","year":"2020","journal-title":"Lupus"},{"key":"2022100812085941200_keac064-B28","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.3899\/jrheum.081141","article-title":"Ethnic differences in pediatric systemic lupus erythematosus","volume":"36","author":"Hiraki","year":"2009","journal-title":"J Rheumatol"},{"key":"2022100812085941200_keac064-B29","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1177\/0961203311416694","article-title":"Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis","volume":"20","author":"Livingston","year":"2011","journal-title":"Lupus"},{"key":"2022100812085941200_keac064-B30","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1093\/rheumatology\/keab173","article-title":"\u2018It is good to have a target in mind\u2019: Qualitative views of patients and parents informing a treat to target clinical trial in JSLE","volume":"60","author":"Smith","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2022100812085941200_keac064-B31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/archdischild-2019-317401","article-title":"Case ascertainment in active paediatric surveillance systems: a report from the British Paediatric Surveillance Unit Ascertainment Group","volume":"105","author":"Lynn","year":"2020","journal-title":"Arch Dis Child"},{"key":"2022100812085941200_keac064-B32","author":"Britich Society for Rheumatology. Paediatric and Adolescent Rheumatology"},{"key":"2022100812085941200_keac064-B33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12969-018-0251-z","article-title":"What do young people with rheumatic conditions in the UK think about research involvement? A qualitative study","volume":"16","author":"Parsons","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"key":"2022100812085941200_keac064-B34","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/S2665-9913(19)30163-8","article-title":"Shifting the mindset - adolescent and young adult rheumatology in transition","volume":"2","author":"Mcdonagh","year":"2020","journal-title":"Lancet Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac064\/42545873\/keac064.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/10\/4097\/46382723\/keac064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/10\/4097\/46382723\/keac064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T12:11:45Z","timestamp":1665231105000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/10\/4097\/6520810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,2,3]]},"published-print":{"date-parts":[[2022,10,6]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac064","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2022,2,3]]}}}